Unknown EARLY_PHASE1 INTERVENTIONAL 2-arm NCT03228524

D-aspartate and Therapeutic Exercise (DAsp&TerapEx)

Promotion of Synaptic Plasticity With D-Aspartate to Favour Recovery Form Cerebral Damage

Sponsor: Neuromed IRCCS

Interventions D-Aspartate Placebo Oral Tablet Therapeutic exercise

Updated 8 times since 2017 Last updated: Mar 13, 2019 Started: Nov 22, 2017 Primary completion: Jul 1, 2020 Completion: Dec 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03228524, this EARLY_PHASE1 trial focuses on Brain Injuries and remains ongoing. Sponsored by Neuromed IRCCS, it has been updated 8 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown EARLY_PHASE1

Status: Unknown Status → Unknown
Feb 2023 — Jul 2024 [monthly]

Unknown Status EARLY_PHASE1

Status: Recruiting → Unknown Status
Jan 2021 — Feb 2023 [monthly]

Recruiting EARLY_PHASE1
Apr 2019 — Jan 2021 [monthly]

Recruiting EARLY_PHASE1

▶ Show 3 earlier versions

Jun 2018 — Apr 2019 [monthly]

Recruiting EARLY_PHASE1
Dec 2017 — Jun 2018 [monthly]

Recruiting EARLY_PHASE1

Status: Not Yet Recruiting → Recruiting
Aug 2017 — Dec 2017 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Neuromed IRCCS

Data source: Neuromed IRCCS

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pozzilli, Italy